Cara Therapeutics Inc. buy marge
Start price
18.04.17
/
50%
€15.22
Target price
21.06.17
€17.14
Performance (%)
13.75%
End price
21.06.17
€17.31
Summary
This prediction ended on 21.06.17 with a price of €17.31. The prediction had a final performance of 13.75%. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cara Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% | 65.292% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% | 97.467% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% | 39.755% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% | 61.093% |
Comments by marge for this prediction
In the thread Cara Therapeutics Inc. diskutieren
marge stimmt der Buy-Einschätzung von datca zu
marge stimmt am 18.04.2017 der Buy-Einschätzung von datca mit dem Kursziel 19$ zu.Überschrift: Cara seems to offer a very positive risk/reward profile at current trading levels.
Stopped prediction by marge for Cara Therapeutics Inc.
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€6.27
31.10.16
31.10.16
€20.75
17.04.17
17.04.17
146.30%
17.04.17
17.04.17
